114 related articles for article (PubMed ID: 26949959)
1. Development of a Novel, Anti-idiotypic Monoclonal Anti-prolactin Antibody That Mimics the Physiological Functions of Prolactin.
Wang M; Zhang DC; Wang ST; Li ML
Asian-Australas J Anim Sci; 2016 Apr; 29(4):571-9. PubMed ID: 26949959
[TBL] [Abstract][Full Text] [Related]
2. Internal image anti-idiotypic antibody: A new strategy for the development a new category of prolactin receptor (PRLR) antagonist.
Lan H; Hong P; Li R; L S; Anshan S; Li S; Zheng X
Mol Immunol; 2017 Jul; 87():86-93. PubMed ID: 28412548
[TBL] [Abstract][Full Text] [Related]
3. Different intracellular signalling pathways triggered by an anti-prolactin receptor (PRLR) antibody: Implication for a signal-specific PRLR agonist.
Kan QE; Su Y; Yang H; Man H
Int J Biol Macromol; 2016 Jan; 82():892-7. PubMed ID: 26526176
[TBL] [Abstract][Full Text] [Related]
4. Development of a new anti-prolactin receptor (PRLR) antibody, F56, which can serve as a PRLR antagonist.
Cui H; Ma YZ; Wang Y; Song M; Zhang H
Int J Biol Macromol; 2017 Feb; 95():1223-1227. PubMed ID: 27829125
[TBL] [Abstract][Full Text] [Related]
5. Development and Characterization of a Novel Anti-idiotypic Monoclonal Antibody to Growth Hormone, Which Can Mimic Physiological Functions of Growth Hormone in Primary Porcine Hepatocytes.
Lan HN; Jiang HL; Li W; Wu TC; Hong P; Li YM; Zhang H; Cui HZ; Zheng X
Asian-Australas J Anim Sci; 2015 Apr; 28(4):573-83. PubMed ID: 25656185
[TBL] [Abstract][Full Text] [Related]
6. Preparation of a Growth Hormone Receptor/Prolactin Receptor Bispecific Antibody Antagonist Which Exhibited Anti-Cancer Activity.
Chen X; Wu D; Zheng Y; Liu X; Wang J
Front Pharmacol; 2020; 11():598423. PubMed ID: 33362552
[TBL] [Abstract][Full Text] [Related]
7. A Neutralizing Prolactin Receptor Antibody Whose In Vivo Application Mimics the Phenotype of Female Prolactin Receptor-Deficient Mice.
Otto C; Särnefält A; Ljungars A; Wolf S; Rohde-Schulz B; Fuchs I; Schkoldow J; Mattsson M; Vonk R; Harrenga A; Freiberg C
Endocrinology; 2015 Nov; 156(11):4365-73. PubMed ID: 26284426
[TBL] [Abstract][Full Text] [Related]
8. The activation and differential signalling of the growth hormone receptor induced by pGH or anti-idiotypic monoclonal antibodies in primary rat hepatocytes.
Li W; Lan H; Liu H; Fu Z; Yang Y; Han W; Guo F; Liu Y; Zhang H; Liu J; Zheng X
Mol Cell Endocrinol; 2013 Aug; 376(1-2):51-9. PubMed ID: 23769824
[TBL] [Abstract][Full Text] [Related]
9. Changes in numbers of prolactin receptors during the cell cycle of Nb2 cells.
Camarillo IG; Rillema JA
J Endocrinol; 1998 Oct; 159(1):R1-4. PubMed ID: 9799870
[TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of the prolactin receptor expression in human breast cancer.
Galsgaard ED; Rasmussen BB; Folkesson CG; Rasmussen LM; Berchtold MW; Christensen L; Panina S
J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH.
Gertler A; Shamay A; Cohen N; Ashkenazi A; Friesen HG; Levanon A; Gorecki M; Aviv H; Hadary D; Vogel T
Endocrinology; 1986 Feb; 118(2):720-6. PubMed ID: 2417826
[TBL] [Abstract][Full Text] [Related]
12. Antiidiotypic antibodies raised against anti-prolactin (PRL) antibodies recognize the PRL receptor.
Amit T; Barkey RJ; Gavish M; Youdim MB
Endocrinology; 1986 Feb; 118(2):835-43. PubMed ID: 3002768
[TBL] [Abstract][Full Text] [Related]
13. Prolactin receptor expression in the epithelia and stroma of the rat mammary gland.
Camarillo IG; Thordarson G; Moffat JG; Van Horn KM; Binart N; Kelly PA; Talamantes F
J Endocrinol; 2001 Oct; 171(1):85-95. PubMed ID: 11572793
[TBL] [Abstract][Full Text] [Related]
14. A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice.
Binart N; Imbert-Bollore P; Baran N; Viglietta C; Kelly PA
Mol Endocrinol; 2003 Jun; 17(6):1066-74. PubMed ID: 12624115
[TBL] [Abstract][Full Text] [Related]
15. Anti-idiotypic antibody: A new strategy for the development of a growth hormone receptor antagonist.
Lan H; Zheng X; Khan MA; Li S
Int J Biochem Cell Biol; 2015 Nov; 68():101-8. PubMed ID: 26369868
[TBL] [Abstract][Full Text] [Related]
16. N-glycosylation of the prolactin receptor is not required for activation of gene transcription but is crucial for its cell surface targeting.
Buteau H; Pezet A; Ferrag F; Perrot-Applanat M; Kelly PA; Edery M
Mol Endocrinol; 1998 Apr; 12(4):544-55. PubMed ID: 9544990
[TBL] [Abstract][Full Text] [Related]
17. Prolactin regulation of pim-1 expression: positive and negative promoter elements.
Borg KE; Zhang M; Hegge D; Stephen RL; Buckley DJ; Magnuson NS; Buckley AR
Endocrinology; 1999 Dec; 140(12):5659-68. PubMed ID: 10579330
[TBL] [Abstract][Full Text] [Related]
18. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
19. The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes.
Clevenger CV; Medaglia MV
Mol Endocrinol; 1994 Jun; 8(6):674-81. PubMed ID: 7935483
[TBL] [Abstract][Full Text] [Related]
20. Characterization and applications of monoclonal antibodies to the prolactin receptor.
Okamura H; Zachwieja J; Raguet S; Kelly PA
Endocrinology; 1989 May; 124(5):2499-508. PubMed ID: 2707162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
